sellWeak cluster of 1110b5-1 plan
Ariel Hurley sold $297k of BPMC
PRINCIPAL ACCOUNTING OFFICER at Blueprint Medicines Corp. 3,203 shares at an average of $92.62, traded Mar 3, 2025, filed Mar 4, 2025.
Warning score
29Value
$297k
3,203 shares
Holdings after
18,270
-15% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +14Trade size$297k at market
- +5Share of holdings soldSold 15% of holdings
- +15Cluster11 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-25-006608, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 1, 2025 | AGrant or award Common Stock10b5-1 | +6,506 | $0.00 | $0 | 21,473 | Mar 4, 2025 |
| Mar 3, 2025 | SOpen-market sale Common Stock10b5-1 | -775 | $89.63 | $69k | 20,698 | Mar 4, 2025 |
| Mar 3, 2025 | SOpen-market sale Common Stock10b5-1 | -238 | $90.92 | $22k | 20,460 | Mar 4, 2025 |
| Mar 3, 2025 | SOpen-market sale Common Stock10b5-1 | -631 | $92.00 | $58k | 19,829 | Mar 4, 2025 |
| Mar 3, 2025 | SOpen-market sale Common Stock10b5-1 | -484 | $93.42 | $45k | 19,345 | Mar 4, 2025 |
| Mar 3, 2025 | SOpen-market sale Common Stock10b5-1 | -1,075 | $95.16 | $102k | 18,270 | Mar 4, 2025 |
| Mar 1, 2025 | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +7,007 | $95.67 | $670k | 7,007 | Mar 4, 2025 |
Related signals
Other insiders at Blueprint Medicines Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 34Weak | Blueprint Medicines Corp | Percy H. Carter CHIEF SCIENTIFIC OFFICER | $135k 1,051 shares | -2% | |
| 39Weak | Blueprint Medicines Corp | Christina Rossi CHIEF OPERATING OFFICER | $150k 1,172 shares | -2% | |
| 38Weak | Blueprint Medicines Corp | Percy H. Carter CHIEF SCIENTIFIC OFFICER | $340k 2,659 shares | -5% | |
| 13Weak | Blueprint Medicines Corp | Jeffrey W. Albers director | $506k 5,000 shares | -3% | |
| 28Weak | Blueprint Medicines Corp | Christina Rossi CHIEF OPERATING OFFICER | $229k 2,274 shares | -3% | |
| 7Weak | Blueprint Medicines Corp | Ariel Hurley PRINCIPAL ACCOUNTING OFFICER | $284k 2,752 shares | -14% | |
| 21Weak | Blueprint Medicines Corp | Christina Rossi CHIEF OPERATING OFFICER | $231k 2,274 shares | -3% | |
| 25Weak | Blueprint Medicines Corp | Kate Haviland CHIEF EXECUTIVE OFFICER | $216k 2,498 shares | -1% | |
| 27Weak | Blueprint Medicines Corp | Christina Rossi CHIEF OPERATING OFFICER | $216k 2,274 shares | -3% | |
| 48Moderate | Blueprint Medicines Corp | Jeffrey W. Albers director | $512k 5,766 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.